[PDF][PDF] Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer's disease

…, M Tzioras, A Stevenson, M d'Orange, M Hooley… - Cell reports, 2019 - cell.com
A key knowledge gap blocking development of effective therapeutics for Alzheimer's disease
(AD) is the lack of understanding of how amyloid beta (Aβ) peptide and pathological forms …

[HTML][HTML] Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

Z Jiwaji, SS Tiwari, RX Avilés-Reyes, M Hooley… - Nature …, 2022 - nature.com
Alzheimer’s disease (AD) alters astrocytes, but the effect of Aß and Tau pathology is poorly
understood. TRAP-seq translatome analysis of astrocytes in APP/PS1 ß-amyloidopathy and …

Longitudinal changes of white matter hyperintensities in sporadic small vessel disease: a systematic review and meta-analysis

…, C Arteaga, F Chappell, T Ritakari, M Hooley… - Neurology, 2022 - AAN Enterprises
Background and Objectives White matter hyperintensities (WMHs) are frequent imaging
features of small vessel disease (SVD) and related to poor clinical outcomes. WMH progression …

[HTML][HTML] Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias

JD Hothersall, R Torella, S Humphreys, M Hooley… - …, 2017 - Elsevier
The development of G protein-biased agonists for the μ-opioid receptor (MOR) offers a clear
drug discovery rationale for improved analgesia and reduced side-effects of opiate …

Investigating astrocyte dysfunction in mouse models of Alzheimer's disease

M Hooley - 2021 - era.ed.ac.uk
Every 3 seconds someone in the world is diagnosed with dementia. This staggering fact is
compounded by another, 60-80% of these patients are suffering from the same disease, …

[PDF][PDF] Translational neuroscience: the state of the nation (a PhD student perspective)

C Davies, OKL Hamilton, M Hooley… - Brain …, 2020 - academic.oup.com
Many brain disorders are currently untreatable. It has been suggested that taking a ‘translational’
approach to neuroscientific research might change this. We discuss what ‘translational …

[HTML][HTML] Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion

…, S Syvänen, V Giedraitis, M Hooley… - Acta neuropathologica …, 2024 - Springer
Deposition of amyloid beta (Aβ) into plaques is a major hallmark of Alzheimer’s disease (AD).
Different amyloid precursor protein (APP) mutations cause early-onset AD by altering the …

[HTML][HTML] Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease

…, D King, F Gobbo, C Davies, M Hooley… - Acta …, 2024 - Springer
Synapse loss correlates with cognitive decline in Alzheimer’s disease, and soluble oligomeric
amyloid beta (Aβ) is implicated in synaptic dysfunction and loss. An important knowledge …

Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model

…, BT Hyman, L Wilkins, M Hooley… - Brain and …, 2023 - journals.sagepub.com
A key hallmark of Alzheimer’s disease (AD) is the accumulation of hyperphosphorylated tau
in neurofibrillary tangles. This occurs alongside neuroinflammation and neurodegeneration. …

[HTML][HTML] D. Mali

J Hooley - Women, Work, and Economic Growth - elibrary.imf.org
Mali has one of the highest levels of gender inequality in the world. The World Economic
Forum ranks Mali 138th out of 142 countries for gender equality, and its score has worsened …